Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Clinical Research Coordinator (Lung Team) - 40360 University Staff Description University of Colorado Anschutz Medical Campus Department: Cancer Center – CCTO (Lung Team) Working Title: Clinical Research Coordinator (Lung Team) Position #: 00680442 – Requisition #: 40360 Job Summary:
Clinical Research Coordinator (Lung Team)( Job Number: 40360) Description University of Colorado Anschutz Medical Campus Department: Cancer Center – CCTO (Lung Team) Working Title: Clinical Research Coordinator (Lung Team) Position #: 00680442 – Requisition #: 40360 Job Summary: Clinical
Regeneron is growing its newly established International Oncology organisation and is seeking a Sales Specialist to join the UK sales team. This role focuses on engaging oncology healthcare professionals, supporting effective clinical practice through high‑quality scientific
The Job Details are as follows: Who We Are We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter
We anticipate the application window for this opening will close on - 13 Jul 2026 Careers that change lives start here. Medtronic is a global leader in healthcare technology with a Mission to alleviate pain, restore
Role Summary Pfizer Commercial Oncology is introducing the world to the next era of cancer care. With a growing portfolio of novel therapies, industry-leading R&D, and a goal of delivering eight breakthroughs by 2030 across major
Career CategoryMarketing Job Description At Amgen, if you feel like you are part of something bigger, it is because you are. Our shared mission - to serve patients living with serious illnesses - drives all that
Job Description Summary REMOTE POSITION, ROTATING NIGHTS/WEEKENDS/HOLIDAYS, REQUIRES HIGHLY MOTIVATED INDIVIDUAL Training required for this position is a minimum of 3 months and takes place on-site, downtown Charleston campus, and remotely with their preceptor. Must be
Company Overview DeepHealth, a RadNet company, is focused on delivering AI-powered solutions that improve population health, optimize radiology workflows, and drive earlier detection of disease. Our portfolio spans breast, lung, brain, prostate, and thyroid imaging AI, deployed
California, US residents click here. The job details are as follows: Who We Are We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose
This is a remote/hybrid position. Requires onsite occasionally, potentially 4 times a year or as needed The Product Owner III is responsible for executing the strategic direction, continuous improvement, functional and technical roadmap for the product